Shigella flexneri serotype 3a: the rise of a superbug.
作者信息
Agaisse Hervé
机构信息
Department of Microbial Pathogenesis, Yale School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT, USA.
出版信息
Lancet Infect Dis. 2015 Aug;15(8):867-8. doi: 10.1016/S1473-3099(15)00003-1. Epub 2015 Apr 27.
Abstract
摘要
相似文献
1
Shigella flexneri serotype 3a: the rise of a superbug.
Lancet Infect Dis. 2015 Aug;15(8):867-8. doi: 10.1016/S1473-3099(15)00003-1. Epub 2015 Apr 27.
2
Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study.
Lancet Infect Dis. 2015 Aug;15(8):913-21. doi: 10.1016/S1473-3099(15)00002-X. Epub 2015 Apr 27.
3
Azithromycin-Nonsusceptible Shigella flexneri 3a in Men Who Have Sex with Men, Taiwan, 2015-2016.
Emerg Infect Dis. 2016 Feb;23(2):345-346. doi: 10.3201/eid2302.161260.
4
Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012-2015.
Emerg Infect Dis. 2020 Apr;26(4):667-674. doi: 10.3201/eid2604.191031.
5
Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.
Infection. 2014 Aug;42(4):789-90. doi: 10.1007/s15010-014-0594-4. Epub 2014 Feb 2.
6
Outbreak of locally acquired azithromycin-resistant Shigella flexneri infection in men who have sex with men.
Pathology. 2015 Jan;47(1):87-8. doi: 10.1097/PAT.0000000000000207.
7
Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015.
Emerg Infect Dis. 2016 Nov;22(11):2016-2018. doi: 10.3201/eid2211.160883.
8
Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.
Emerg Infect Dis. 2016 Jun;22(6):1083-5. doi: 10.3201/eid2206.152088.
9
Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China.
Microb Drug Resist. 2017 Jul;23(5):596-601. doi: 10.1089/mdr.2016.0134. Epub 2016 Nov 14.
10
The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
BMC Infect Dis. 2016 Nov 18;16(1):685. doi: 10.1186/s12879-016-1977-1.
引用本文的文献
1
On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.
Medchemcomm. 2019 Jun 20;10(8):1273-1289. doi: 10.1039/c9md00146h. eCollection 2019 Aug 1.
2
Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD.
ChemMedChem. 2017 Sep 21;12(18):1534-1541. doi: 10.1002/cmdc.201700348. Epub 2017 Aug 31.
3
The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America.
Braz J Microbiol. 2016 Oct-Dec;47(4):800-806. doi: 10.1016/j.bjm.2016.07.019. Epub 2016 Jul 26.
本文引用的文献
1
Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study.
Lancet Infect Dis. 2015 Aug;15(8):913-21. doi: 10.1016/S1473-3099(15)00002-X. Epub 2015 Apr 27.
2
Origin and proliferation of multiple-drug resistance in bacterial pathogens.
Microbiol Mol Biol Rev. 2015 Mar;79(1):101-16. doi: 10.1128/MMBR.00039-14.
3
Preparing for an era of untreatable gonorrhea.
Curr Opin Infect Dis. 2014 Jun;27(3):282-7. doi: 10.1097/QCO.0000000000000058.
4
Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.
Lancet Infect Dis. 2014 Mar;14(3):220-6. doi: 10.1016/S1473-3099(13)70693-5. Epub 2014 Jan 22.
5
Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011.
Euro Surveill. 2012 Mar 29;17(13):20137.
6
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.
Int J Antimicrob Agents. 2012 Jul;40(1):9-17. doi: 10.1016/j.ijantimicag.2012.02.005. Epub 2012 Apr 5.
7
Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.
Curr Opin Infect Dis. 2012 Feb;25(1):73-8. doi: 10.1097/QCO.0b013e32834e9a6a.
8
Approach to the patient with infectious colitis.
Curr Opin Gastroenterol. 2012 Jan;28(1):39-46. doi: 10.1097/MOG.0b013e32834d3208.
9
The antibiotic resistome: the nexus of chemical and genetic diversity.
Nat Rev Microbiol. 2007 Mar;5(3):175-86. doi: 10.1038/nrmicro1614.
10
Contagious acute gastrointestinal infections.
N Engl J Med. 2004 Dec 2;351(23):2417-27. doi: 10.1056/NEJMra041837.
Zotero 插件